3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
4
Lung Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pain
2
Lymphoma
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Postoperative Hemorrhage
1
Polyposis, Gastric
1
Oropharyngeal Neoplasms
1
Nerve Block
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Musculoskeletal Diseases
1
Multiple Myeloma
1
Mouth Neoplasms
1
Malignant Neoplasms of Male Genital Organs
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Leukemia
1
Leiomyoma
1
Hypotension
1
Hodgkin Disease
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Radiotherapy, Intensity-Modulated
11
Paclitaxel
11
Carboplatin
11
Fluorouracil
10
Biopsy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Drug Therapy
9
Taxes
7
Surgical Procedures, Operative
7
Celecoxib
7
X-Rays
6
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Surveys and Questionnaires
5
Nivolumab
5
cemiplimab
4
Metformin
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Chemoradiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mouth Neoplasms
×
Epinephrine
×
Clear all
NCT01418118
2011-08-16
Free4Flow
Oxford University Hospitals NHS Trust
Phase 4
Completed
25 enrolled